Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | -6.34% | -11.92% | -26.14% |
Chart calendar Tempest Therapeutics, Inc.
Upcoming events on Tempest Therapeutics, Inc.
Past events on Tempest Therapeutics, Inc.
2024-05-09 04:29 pm | Q1 2024 Earnings Release |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 3045 |
2024-03-19 04:25 pm | Q4 2023 Earnings Release |
2024-03-04 09:10 am | TD Cowen Health Care Conference |
2023-11-28 03:00 pm | Piper Sandler Healthcare Conference |
2023-11-08 05:17 pm | Q3 2023 Earnings Release |
2023-10-11 08:30 am | TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:13 pm | Q2 2023 Earnings Release |
2023-06-15 04:00 pm | Annual General Meeting |
2023-06-07 02:00 pm | Jefferies Global Healthcare Conference |
2023-06-03 08:00 am | American Society of Clinical Oncology Conference - Abstract Number : 3107 |
2023-05-10 04:15 pm | Q1 2023 Earnings Release |
2023-04-28 08:30 am | TPST-1120 Phase 1b/2 Study Results Call |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No 2130 |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No 1636 |
2023-03-22 05:26 pm | Q4 2022 Earnings Release |
2023-03-16 | Society for Immunotherapy of Cancer Spring Scientific Meeting - Abstract Number:78 |
2022-11-29 11:30 am | Piper Sandler Healthcare Conference |
2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract No 1471 |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -27,0 -27,8 2.93% | -34,6 -36,0 3.78% | -28,8 -29,6 2.78% | -35,5 |
EBIT Million USD | Released Forecast Spread | 0,00 | -27,0 -27,8 2.99% | -34,6 -35,3 1.8% | -29,2 -28,8 -1.28% | -33,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -35,7 -36,0 0.84% | -29,5 -29,5 -0.14% | -36,2 |
Net income Million USD | Released Forecast Spread | -19,2 | 0,00 0,00 - | -35,7 -36,0 0.84% | -29,5 -29,5 -0.14% | -32,1 |
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -3,09 -3,52 12.22% | -1,91 -1,94 1.29% | -1,52 |
Announcement Date | 13/04/21 | 29/03/22 | 22/03/23 | 19/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
EBITDA Million USD | Released Forecast Spread | -8,66 -8,40 -3.12% | -8,77 -9,40 6.69% | -8,93 -10,3 13.26% | -7,58 -9,10 16.69% | -7,39 -8,70 15.09% | -6,50 -8,10 19.7% | -7,43 -8,00 7.14% | -7,89 -7,80 -1.1% | -8,30 | -8,70 | -10,6 | |||
EBIT Million USD | Released Forecast Spread | -8,16 -7,44 -9.72% | -8,77 -8,60 -1.98% | -8,77 -9,12 3.78% | -8,93 -9,33 4.2% | -7,58 -8,98 15.53% | -7,47 -7,82 4.52% | -6,59 -7,71 14.47% | -7,51 -6,92 -8.63% | -7,97 -7,61 -4.8% | -7,85 | -8,01 | -8,94 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,10 -9,41 3.22% | -7,64 -9,14 16.44% | -7,58 -7,95 4.69% | -6,79 -7,84 13.39% | -7,49 -7,32 -2.35% | -7,90 -7,61 -3.84% | -8,40 | -8,80 | -11,0 | |||||
Net income Million USD | Released Forecast Spread | -9,10 -9,41 3.22% | -7,64 -9,14 16.44% | -7,58 -7,95 4.69% | -6,79 -7,84 13.39% | -7,49 -7,32 -2.35% | -7,90 -7,61 -3.84% | -8,40 | -8,80 | -11,0 | |||||
EPS USD | Released Forecast Spread | -0,63 -0,89 29.21% | -0,55 -0,62 11.29% | -0,54 -0,48 -13.29% | -0,48 -0,57 15.29% | -0,34 -0,39 12.07% | -0,36 -0,37 3.74% | -0,40 | -0,37 | -0,36 | -0,54 | -0,62 | |||
Announcement Date | 13/05/22 | 15/08/22 | 08/11/22 | 22/03/23 | 10/05/23 | 10/08/23 | 08/11/23 | 19/03/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Tempest Therapeutics, Inc.
2024-05-10 07:00 am | HUMACYTE, INC.: Q1 2024 Earnings Release |
2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:10 pm | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | HILLEVAX, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TPST Stock
- Calendar Tempest Therapeutics, Inc.